Citations (108)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Abdulsalam M Halboup, Karem H Alzoubi, Mohamed Izham Mohamed Ibrahim, Syed Azhar Syed Sulaiman, Yasmin Almahbashi, Shaima Al-Arifi, Sarah Mohammed & Gamil Othman. (2022) Awareness and Perception of Hospitalized Patients on Thromboembolism and Thromboprophylaxis: A Cross-Sectional Study in Sana’a-Yemen. Patient Preference and Adherence 16, pages 1649-1661.
Read now
Read now
John R. Burton, Mahesh V. Madhavan, Matthew Finn, Joseph J. Ingrassia, Behnood Bikdeli, Shayan Nabavi Nouri, Yevgeniy Brailovsky, Erika B. Rosenzweig, Koji Takeda, Philip Green, Ajay J. Kirtane, Sahil A. Parikh & Sanjum S. Sethi. (2021) Advanced Therapies for Acute Pulmonary Embolism: A Focus on Catheter-Based Therapies and Future Directions. Structural Heart 5:2, pages 103-119.
Read now
Read now
Hansen Deng, John K. Yue & Doris D. Wang. (2021) Trends in safety and cost of deep brain stimulation for treatment of movement disorders in the United States: 2002–2014. British Journal of Neurosurgery 35:1, pages 57-64.
Read now
Read now
Rhodri Saunders, Anthony J Comerota, Audrey Ozols, Rafael Torrejon Torres & Kwok Ming Ho. (2018) Intermittent pneumatic compression is a cost-effective method of orthopedic postsurgical venous thromboembolism prophylaxis. ClinicoEconomics and Outcomes Research 10, pages 231-241.
Read now
Read now
Setor K. Kunutsor, Samuel Seidu & Kamlesh Khunti. (2018) Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence. Annals of Medicine 50:6, pages 529-537.
Read now
Read now
George Dranitsaris, Lesley G Shane, Mark Crowther, Guillaume Feugere & Seth Woodruff. (2017) Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis. ClinicoEconomics and Outcomes Research 9, pages 65-73.
Read now
Read now
C. Browne, T. Lanitis, M. Hamilton, X. Li, R. Horbyluk, J. Mardekian, T. Kongnakorn & A. Cohen. (2017) Impact of apixaban vs low molecular weight heparin/vitamin k antagonist on hospital resource use in patients with venous thromboembolism. Journal of Medical Economics 20:1, pages 98-106.
Read now
Read now
Articles from other publishers (100)
Gregory J. KirchnerAndrew Kim, Alexander M. LieberShawn M. HinesLucas E. Nikkel. (2023) Cannabis Use Does Not Increase Risk of Perioperative Complications Following Primary Total Hip Arthroplasty: A Cohort-Matched Comparison. Cannabis and Cannabinoid Research 8:4, pages 684-690.
Crossref
Crossref
Francesco Lancellotti, Diego Coletta, Nicola de’Liguori Carino, Thomas Satyadas, Santhalingam Jegatheeswaran, Martina Maruccio, Aali J. Sheen, Ajith K. Siriwardena & Saurabh Jamdar. (2023) Venous thromboembolism (VTE) after open hepatectomy compared to minimally invasive liver resection: a systematic review and meta-analysis. HPB 25:8, pages 872-880.
Crossref
Crossref
Matthew D. Haller, Hyung J. Cho, Jennifer Ahn, Mona Krouss, Daniel Alaiev, Garrett H. Yoon, Andrew S. Dunn & Ian Fagan. (2023) Initiative to reduce inappropriate venous thromboembolism prophylaxis in an 11‐hospital safety net system: An electronic health records‐based approach. Journal of Hospital Medicine 18:6, pages 502-508.
Crossref
Crossref
Cindy M.M. de Jong, Rachel P. Rosovsky & Frederikus A. Klok. (2023) Outcomes of venous thromboembolism care: future directions. Journal of Thrombosis and Haemostasis 21:5, pages 1082-1089.
Crossref
Crossref
Rachael N. Piver, Vincent M. Wagner, Monica D. Levine, Floor J. Backes, Laura J. Chambers, David E. Cohn, Larry J. Copeland, Casey M. Cosgrove, Christa I. Nagel, David M. O'Malley & Kristin L. Bixel. (2023) Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer. Gynecologic Oncology Reports 46, pages 101156.
Crossref
Crossref
Jang Ho Lee, Hoon Hee Lee, Hyung Jun Park, Seonok Kim, Ye-Jee Kim, Jae Seung Lee & Ho Cheol Kim. (2023) Venous thromboembolism in patients with idiopathic pulmonary fibrosis, based on nationwide claim data. Therapeutic Advances in Respiratory Disease 17, pages 175346662311557.
Crossref
Crossref
Shirin Ardeshirrouhanifard, Michael I. Ellenbogen, Jodi B. Segal, Michael B. Streiff, Steven B. Deitelzweig & Daniel J. Brotman. (2023) Healthcare utilization differences between an apixaban-based and warfarin-based strategy for acute venous thromboembolism in patients with end-stage kidney disease. Thrombosis Research 221, pages 45-50.
Crossref
Crossref
Seung-Kee Min, Ji-Sun Kim, Jang Yong Kim, Ui Jun Park, Taehoon Lee, Jin Mo Kang, Sun Cheol Park, Won-Il Choi, Ki-Hyuk Park & Martin Gebel. (2022) Characteristics and Effect of Rivaroxaban on Venous Thromboembolism in Korean Patients Compared to Western Population: A Subgroup Analysis from XALIA(-LEA) Study. Vascular Specialist International 38.
Crossref
Crossref
Donglin Fu, Li Li, Yifan Li, Xiaofei Liu, Hongkang Chen, Naitian Wu & Guangfeng Sun. (2022) Fondaparinux sodium and low molecular weight heparin for venous thromboembolism prophylaxis in Chinese patients with major orthopedic surgery or trauma: a real-world study. BMC Surgery 22:1.
Crossref
Crossref
Salah Eddine Ousama Kacimi, Aysan Moeinafshar, Shirin Shahsavar Haghighi, Amene Saghazadeh & Nima Rezaei. (2022) Venous thromboembolism in cancer and cancer immunotherapy. Critical Reviews in Oncology/Hematology 178, pages 103782.
Crossref
Crossref
Monish Karunakaran, Ramneek Kaur, Simi Ismail, Sushma Cherukuru, Pavan Kumar Jonnada, Baiju Senadhipan & Savio George Barreto. (2022) Post-hepatectomy venous thromboembolism: a systematic review with meta-analysis exploring the role of pharmacological thromboprophylaxis. Langenbeck's Archives of Surgery 407:8, pages 3221-3233.
Crossref
Crossref
Atsushi Kainuma, Yuming Ning, Paul A. Kurlansky, Amy S. Wang, Farhana Latif, Maryjane A. Farr, Gabriel T. Sayer, Nir Uriel, Hiroo Takayama, Yoshifumi Naka & Koji Takeda. (2022) Deep vein thrombosis and pulmonary embolism after heart transplantation. Clinical Transplantation 36:7.
Crossref
Crossref
Semran B. Thamer, Aaron W. Lam, Ivan J. Golub, Matthew L. Magruder, Rushabh M. Vakharia, Amiethab A. Aiyer & Amr A. Abdelgawad. (2022) Sleep Apnea and Postoperative Medical Complications and Health Care Expenditures Following Open Reduction and Internal Fixation of Bimalleolar Ankle Fractures. Foot & Ankle Specialist, pages 193864002210986.
Crossref
Crossref
Aanuoluwapo Obisesan, Vinay Singhal & Savni Satoskar. (2021) Robotic-assisted hiatal hernia repair and pulmonary embolism: an institution-based retrospective cohort study. Journal of Robotic Surgery 16:3, pages 501-505.
Crossref
Crossref
Dana E. Angelini & Alok A. Khorana. (2022) Building a CAT clinic - real-world systems approaches to prevention and treatment. Thrombosis Research 213, pages S84-S86.
Crossref
Crossref
Max D. Hazeltine, Erin M. Scott & Jon D. Dorfman. (2021) An abbreviated Caprini model for VTE risk assessment in trauma. Journal of Thrombosis and Thrombolysis 53:4, pages 878-886.
Crossref
Crossref
David Jiménez, Carmen Rodríguez, Beatriz Pintado, Andrea Pérez, Luis Jara-Palomares, Raquel López-Reyes, Pedro Ruiz-Artacho, Alberto García-Ortega, Behnood Bikdeli & José Luis Lobo. (2022) Effect of Prognostic Guided Management of Patients With Acute Pulmonary Embolism According to the European Society of Cardiology Risk Stratification Model. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Stephan V. Hendriks, Wilbert B. van den Hout, Thomas van Bemmel, Ingrid M. Bistervels, Michiel Eijsvogel, Laura M. Faber, Herman M. A. Hofstee, Tom van der Hulle, Antonio Iglesias del Sol, Marieke J. H. A. Kruip, Albert T. A. Mairuhu, Saskia Middeldorp, Mathilde Nijkeuter, Menno V. Huisman & Frederikus A. Klok. (2021) Home Treatment Compared to Initial Hospitalization in Normotensive Patients with Acute Pulmonary Embolism in the Netherlands: A Cost Analysis. Thrombosis and Haemostasis 122:03, pages 427-433.
Crossref
Crossref
Dana E. Angelini & Alok A. Khorana. (2022) WITHDRAWN: Building a CAT clinic - real-world systems approaches to prevention and treatment. Thrombosis Research.
Crossref
Crossref
David Jiménez, Carmen Rodríguez, Francisco León, Luis Jara-Palomares, Raquel López-Reyes, Pedro Ruiz-Artacho, Teresa Elías, Remedios Otero, Alberto García-Ortega, Agustina Rivas-Guerrero, Jaime Abelaira, Sonia Jiménez, Alfonso Muriel, Raquel Morillo, Deisy Barrios, Raphael Le Mao, Roger D. Yusen, Behnood Bikdeli, Manuel Monreal & José Luis Lobo. (2022) Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism. European Respiratory Journal 59:2, pages 2100412.
Crossref
Crossref
Mulugeta Asmamaw, Wubet Hungnaw, Achenef Motbainor, Hanan Muzeyin Kedir & Tamrat Assefa Tadesse. (2022) Incidence of thromboembolism and thromboprophylaxis in medical patients admitted to specialized hospital in Ethiopia using Padua prediction score. SAGE Open Medicine 10, pages 205031212210794.
Crossref
Crossref
Akihiko Akamine, Naonobu Takahira, Masayuki Kuroiwa, Atsushi Tomizawa & Koichiro Atsuda. (2022) Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty. Clinical and Applied Thrombosis/Hemostasis 28, pages 107602962211038.
Crossref
Crossref
Cécile Duval, Caroline Sirois, Félix H. Savoie-White, Pier-Alexandre Tardif, Mélanie Bérubé, Alexis F. Turgeon, Deborah J. Cook, François Lauzier & Lynne Moore. (2022) Effect of Intermittent Pneumatic Compression in Addition to Pharmacologic Prophylaxis for Thromboprophylaxis in Hospitalized Adult Patients: A Systematic Review and Meta-Analysis. Critical Care Explorations 4:10, pages e0769.
Crossref
Crossref
Sarah Landry, Shannon Ip, Jennifer Shiu & Tammy J. Bungard. (2021) Practice patterns surrounding referral to a specialty venous thromboembolism (VTE) clinic: a retrospective review. Journal of Thrombosis and Thrombolysis 53:1, pages 176-181.
Crossref
Crossref
Sean A. Perez, Shriya B. Reddy, Amanda Meister, Emma Pinjic, Kei Suzuki & Virginia R. Litle. (2021) Venous thromboembolism in benign esophageal surgery patients: potential cost effectiveness of Caprini risk stratification. Surgical Endoscopy 36:1, pages 764-770.
Crossref
Crossref
. (2021) Publisher note. Thrombosis Research 208, pages 173-175.
Crossref
Crossref
Hansen DENG, John K. YUE, Angel ORDAZ, Catherine G. SUEN & David C. SING. (2021) Elective lumbar fusion in the United States: national trends in inpatient complications and cost from 2002-2014. Journal of Neurosurgical Sciences 65:5.
Crossref
Crossref
Jonathan J. Hue, Erryk Katayama, Sarah C. Markt, Luke D. Rothermel, Jeffrey M. Hardacre, John B. Ammori, Jordan M. Winter & Lee M. Ocuin. (2020) Association Between Operative Approach and Venous Thromboembolism Rate Following Hepatectomy: a Propensity-Matched Analysis. Journal of Gastrointestinal Surgery 25:11, pages 2778-2787.
Crossref
Crossref
Rachel R. Blitzer & Samuel Eisenstein. (2021) Venous Thromboembolism and Pulmonary Embolism. Surgical Clinics of North America 101:5, pages 925-938.
Crossref
Crossref
Armando Tripodi, Simona C. Rossi, Marigrazia Clerici, Giuliana Merati, Erica Scalambrino, Ilaria Mancini, Luciano Baronciani, Marco Boscarino, Valter Monzani & Flora Peyvandi. (2021) Pro-coagulant imbalance in patients with community acquired pneumonia assessed on admission and one month after hospital discharge. Clinical Chemistry and Laboratory Medicine (CCLM) 59:10, pages 1699-1708.
Crossref
Crossref
Chun Hin Angus Lee, Xuefei Jia, Jeremy M. Lipman, Amy L. Lightner, Tracy L. Hull, Scott R. Steele & Stefan D. Holubar. (2021) Defining the Economic Burden of Perioperative Venous Thromboembolism in Inflammatory Bowel Disease in the United States. Diseases of the Colon & Rectum 64:7, pages 871-880.
Crossref
Crossref
Shaina E. Musco, Shannon M. Smallwood & Jill Gossard. (2019) Development and Evaluation of a Pharmacist-Driven Screening Tool to Identify Patients Presenting to the Emergency Department Who Are Eligible for Outpatient Treatment of Deep Vein Thrombosis. Journal of Pharmacy Practice 34:3, pages 378-385.
Crossref
Crossref
Mei-Chuan Lee, Chia-Te Liao, Han Siong Toh, Chih-Chen Chou, Wei-Ting Chang, Zhih-Cherng Chen, Wen-Shiann Wu, Tsung Yu & Carol Strong. (2020) Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases. Cardiovascular Drugs and Therapy 35:3, pages 539-547.
Crossref
Crossref
Jason Koury, Robert Hellinga, Jennifer Rose, Shirley Abraham & Anjali Subbaswamy. (2021) Evaluation of Anticoagulant Monitoring in Pediatric Patients Receiving Enoxaparin for Treatment of Venous Thrombosis. The Journal of Pediatric Pharmacology and Therapeutics 26:4, pages 346-351.
Crossref
Crossref
Hyung Yoon Kim, Sung-A Chang, Kye Hun Kim, Jae-Young Kim, Woo-Keun Seo, Hyungseop Kim, Jeong-Sook Seo, Sung-Hee Shin, Sang Jae Rhee, Sun Hwa Lee & Jung Sun Cho. (2021) Epidemiology of Venous Thromboembolism and Treatment Pattern of Oral Anticoagulation in Korea, 2009–2016: a Nationwide Study Based on the National Health Insurance Service Database. Journal of Cardiovascular Imaging 29:3, pages 265.
Crossref
Crossref
John K. YUE, Hansen DENG, Ethan A. WINKLER, Angel ORDAZ, Eva M. GILLIS-BUCK, Young M. LEE, Michael M. SAFAEE, Adib A. ABLA, Michael C. HUANG & Sanjay S. DHALL. (2021) Hospital complications and costs of spinal arteriovenous malformations in the United States from 2002-2014. Journal of Neurosurgical Sciences 65:1.
Crossref
Crossref
R. Kanade, M. Mohanka, S. Bollineni, J. Joerns, V. Kaza, J. Murala, M. Peltz, M. Wait, F. Torres & A. Banga. (2021) Characteristics and Outcomes Among Patients With Early Venous Thromboembolic Events After Lung Transplant. Transplantation Proceedings 53:1, pages 303-310.
Crossref
Crossref
Amanda Glickman, Alyse Brennecke, Anna Tayebnejad, Koji Matsuo, Saketh R. Guntupalli & Jeanelle Sheeder. (2020) Cost-effectiveness of apixaban for prevention of venous thromboembolic events in patients after gynecologic cancer surgery. Gynecologic Oncology 159:2, pages 476-482.
Crossref
Crossref
Mark B. Ulanja, Bryce D. Beutler, Daniel Antwi-Amoabeng, Paschal A. Apanga, Alastair E. Moody, Charles E. Willyard, Nageshwara Gullapalli, Killian Boampong-Konam & Aaron T. Bowman. (2020) Patient outcomes in myeloproliferative neoplasm-related thrombosis: Insights from the National Inpatient Sample. Thrombosis Research 194, pages 72-81.
Crossref
Crossref
Ayça Gümüşdağ, Cengiz Burak, Muhammed Süleymanoğlu, Mahmut Yesin, Veysel Ozan Tanık, Yavuz Karabağ, Metin Çağdaş & İbrahim Rencüzoğulları. (2020) The predictive value of RS time for short term mortality in patients with acute pulmonary embolism. Journal of Electrocardiology 62, pages 94-99.
Crossref
Crossref
Owen Gantz, Shanen Mulles, Pavel Zagadailov & Aziz M. Merchant. (2020) Incidence and Cost of Deep Vein Thrombosis in Emergency General Surgery Over 15 Years. Journal of Surgical Research 252, pages 125-132.
Crossref
Crossref
Rushabh M. Vakharia, Curtis T. Adams, Afshin A. Anoushiravani, Joseph O. Ehiorobo, Michael A. Mont & Martin W. Roche. (2020) Chronic Obstructive Pulmonary Disease Is Associated With Higher Rates of Venous Thromboemboli Following Primary Total Knee Arthroplasty. The Journal of Arthroplasty 35:8, pages 2066-2071.e9.
Crossref
Crossref
Supatcha Prasertcharoensuk, Narongchai Wongkonkitsin & Sathienrapong Chantawibul. (2019) Incidence of Pulmonary Embolism in Surgical Patients: Hospital-based. Indian Journal of Surgery 82:4, pages 497-500.
Crossref
Crossref
L. V. Popova, T. B. Kondratieva, M. Z. Kanevskaya, T. L. Aleinikova, E. S. Zykova, А. V. Krivova & A. M. Kuznetsov. (2020) Venous Thromboembolism Prophylaxis in Intensive Care Units (Review). General Reanimatology 16:3, pages 106-125.
Crossref
Crossref
Rushad Patell & Jeffrey I. Zwicker. (2020) Inpatient prophylaxis in cancer patients: where is the evidence?. Thrombosis Research 191, pages S85-S90.
Crossref
Crossref
Peter K. Henke, Susan R. Kahn, Christopher J. Pannucci, Eric A. Secemksy, Natalie S. Evans, Alok A. Khorana, Mark A. Creager & Aruna D. Pradhan. (2020) Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association. Circulation 141:24.
Crossref
Crossref
Nipun Sodhi, Hiba K. Anis, Alexander J. Acuña, Rushabh M. Vakharia, Nicolas S. Piuzzi, Carlos A. Higuera, Martin W. Roche & Michael A. Mont. (2020) The Effects of Opioid Use on Thromboembolic Complications, Readmission Rates, and 90-Day Episode of Care Costs After Total Hip Arthroplasty. The Journal of Arthroplasty 35:6, pages S237-S240.
Crossref
Crossref
Nubio Pfaundler, Andreas Limacher, Odile Stalder, Marie Méan, Nicolas Rodondi, Christine Baumgartner & Drahomir Aujesky. (2020) Prognosis in patients with cancer‐associated venous thromboembolism: Comparison of the RIETE‐VTE and modified Ottawa score. Journal of Thrombosis and Haemostasis 18:5, pages 1154-1161.
Crossref
Crossref
Gülsüm Şeyma KOCA & Yusuf ÇELİK. (2020) VENÖZ TROMBOEMBOLİZMİN MALİYETLERİ VE EKONOMİK YÜKÜNÜN BELİRLENMESİNE İLİŞKİN SİSTEMATİK BİR DERLEME: FARMAEKONOMİK ÖNLEYİCİ BİR TEDAVİ OLARAK DMAHA SYSTEMATIC REVIEW OF THE DETERMINATION OF COSTS AND ECONOMIC BURDEN OF VENOUS THROMBOEMBOLISM: LMWH AS A PHARMAECONOMIC PREVENTIVE THERAPY. İşletme Bilimi Dergisi 8:1, pages 67-95.
Crossref
Crossref
My Hanh Bui, Quang Cuong Le, Duc Hung Duong, Truong Son Nguyen, Binh Giang Tran, Tuan Duc Duong, Tien Hung Tran, Huu Chinh Nguyen, Thi Tuyet Mai Kieu, Hong Ha Nguyen, Long Hoang, Thanh Binh Nguyen, Thanh Viet Pham & Thi Hong Xuyen Hoang. (2020) Economic burden of venous thromboembolism in surgical patients: A propensity score analysis from the national claims database in Vietnam. PLOS ONE 15:4, pages e0231411.
Crossref
Crossref
Nina Gustafsson, Peter Bo Poulsen, Sandra Elkjær Stallknecht, Lars Dybro & Søren Paaske Johnsen. (2020) Societal costs of venous thromboembolism and subsequent major bleeding events: a national register-based study. European Heart Journal - Quality of Care and Clinical Outcomes 6:2, pages 130-137.
Crossref
Crossref
Rushabh M. Vakharia, Nipun Sodhi, Hiba K. Anis, Joseph O. Ehiorobo, Michael A. Mont & Martin W. Roche. (2020) Patients Who Have Cannabis Use Disorder Have Higher Rates of Venous Thromboemboli, Readmission Rates, and Costs Following Primary Total Knee Arthroplasty. The Journal of Arthroplasty 35:4, pages 997-1002.
Crossref
Crossref
Rushabh M. Vakharia, Ajit M. Vakharia, Joseph O. Ehiorobo, Samuel J. Swiggett, Michael A. Mont & Martin W. Roche. (2020) Rheumatoid Arthritis Is Associated With Thromboembolic Complications Following Primary Total Knee Arthroplasty. The Journal of Arthroplasty 35:4, pages 1009-1013.
Crossref
Crossref
Kimberly Cheng & Adam S Faye. (2020) Venous thromboembolism in inflammatory bowel disease. World Journal of Gastroenterology 26:12, pages 1231-1241.
Crossref
Crossref
Yun Bao, Gang Zhao, Shuli Qu, Tengbin Xiong, Xingxing Yao & Bin Wu. (2019) A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting. Clinical Drug Investigation 40:2, pages 161-171.
Crossref
Crossref
Ghadeer K Dawwas, Steven M Smith, Eric Dietrich, Wei-Hsuan Lo-Ciganic & Haesuk Park. (2020) Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism. American Journal of Health-System Pharmacy 77:3, pages 188-195.
Crossref
Crossref
Min Yan, Xiang-Tao Pan, Xu Cheng & Ye Lu. (2020) Characteristics and significance of changes of thrombomodulin and plasma protein C in patients with cancer before and after PICC. Indian Journal of Cancer 57:1, pages 27.
Crossref
Crossref
Rushabh M. Vakharia, Karim G. Sabeh, Wayne B. Cohen-Levy, Nipun Sodhi, Michael A. Mont & Martin W. Roche. (2019) Opioid Disorders Are Associated With Thromboemboli Following Primary Total Knee Arthroplasty. The Journal of Arthroplasty 34:12, pages 2957-2961.
Crossref
Crossref
Amanda R Margolis, Andrea L Porter, Carla E Staresinic & Cheryl A Ray. (2019) Impact of an extended International Normalized Ratio follow-up interval on healthcare use among veteran patients on stable warfarin doses. American Journal of Health-System Pharmacy 76:22, pages 1848-1852.
Crossref
Crossref
Joshua M. Kolz, William R. Aibinder, Robert A. Adams, Robert H. Cofield & John W. Sperling. (2019) Symptomatic Thromboembolic Complications After Shoulder Arthroplasty. Journal of Bone and Joint Surgery 101:20, pages 1845-1851.
Crossref
Crossref
Hun Jee Choe, Koung Jin Suh, Ji Yun Lee, Minyoung Kim, Man Jin Kim, Sung Sup Park, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang & Jong Seok Lee. (2019) Acute pulmonary thromboembolism caused by factor V Leiden mutation in South Korea. Medicine 98:28, pages e16318.
Crossref
Crossref
Xuefeng Shan, Zhiqiang Liu, Muhuyati Wulasihan & Songfeng Ma. (2019) Edoxaban improves atrial fibrillation and thromboembolism through regulation of the Wnt‑β‑induced PI3K/ATK‑activated protein C system. Experimental and Therapeutic Medicine.
Crossref
Crossref
Lorenzo G. Mantovani, Sylvia Haas, Reinhold Kreutz, Kerstin Folkerts, Martin Gebel, Danja Monje, Jonas Schneider, Martin van Eickels, Kurtulus Sahin, Elizabeth Zell, Walter Ageno & Alexander G.G. Turpie. (2019) Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis. European Journal of Internal Medicine 61, pages 29-33.
Crossref
Crossref
Ian A. Buchanan, Michelle Lin, Daniel A. Donoho, Arati Patel, Li Ding, Arun P. Amar, Steven L. Giannotta, William J. Mack & Frank Attenello. (2019) Predictors of Venous Thromboembolism After Nonemergent Craniotomy: A Nationwide Readmission Database Analysis. World Neurosurgery 122, pages e1102-e1110.
Crossref
Crossref
Robert Goggs, Marie-Claude Blais, Benjamin M. Brainard, Daniel L. Chan, Armelle M. deLaforcade, Elizabeth Rozanski & Claire R. Sharp. (2019) American College of Veterinary Emergency and Critical Care (ACVECC) Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines: Small animal. Journal of Veterinary Emergency and Critical Care 29:1, pages 12-36.
Crossref
Crossref
Caroline P. Thirukumaran, Laurent G. Glance, Meredith B. Rosenthal, Helena Temkin‐Greener, Rishi Balkissoon, Addisu Mesfin & Yue Li. (2018) Impact of Medicare's Nonpayment Program on Venous Thromboembolism Following Hip and Knee Replacements. Health Services Research 53:6, pages 4381-4402.
Crossref
Crossref
Philip S. Wells, Martin H. Prins, Jan Beyer-Westendorf, Anthonie W.A. Lensing, Lloyd Haskell, Bennett Levitan, François Laliberté, Veronica Ashton, Yongling Xiao, Dominique Lejeune, Concetta Crivera, Patrick Lefebvre, Qi Zhao, Zhong Yuan, Jeff Schein & Paolo Prandoni. (2018) Health-care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN-CHOICE Trial Population. Chest 154:6, pages 1371-1378.
Crossref
Crossref
Xiangdong Liu, Pengkai Cao, Yunsong Li, Jianing Zhao, Liang Li, Haitao Li & Yanrong Zhang. (2018) Safety and efficacy of pharmacomechanical thrombolysis for acute and subacute deep vein thrombosis patients with relative contraindications. Medicine 97:43, pages e13013.
Crossref
Crossref
Abdelmoniem Moustafa, Hussam Mohammad Alim, Mohammed Andaleeb Chowdhury & Ehab A. Eltahawy. (2018) Postthrombotic Syndrome: Long-Term Sequela of Deep Venous Thrombosis. The American Journal of the Medical Sciences 356:2, pages 152-158.
Crossref
Crossref
Eric A. Secemsky, Kenneth Rosenfield, Kevin F. Kennedy, Michael Jaff & Robert W. Yeh. (2018) High Burden of 30‐Day Readmissions After Acute Venous Thromboembolism in the United States. Journal of the American Heart Association 7:13.
Crossref
Crossref
Susan R Kahn, David R Morrison, Gisèle Diendéré, Alexandre Piché, Kristian B Filion, Adi J Klil-Drori, James D Douketis, Jessica Emed, André Roussin, Vicky Tagalakis, Martin Morris & William Geerts. (2018) Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism. Cochrane Database of Systematic Reviews 2018:4.
Crossref
Crossref
Yusuke Ito, Kengo Noguchi, Yoshiyuki Morishima & Kyoji Yamaguchi. (2018) Tissue-type plasminogen activator transgenic rats for evaluating inhibitors of the activated form of thrombin-activatable fibrinolysis inhibitor. Blood Coagulation & Fibrinolysis 29:3, pages 314-321.
Crossref
Crossref
Jonathan K. Aboagye, Jeremiah W.A. Hayanga, Brandyn D. Lau, Errol L. Bush, Dauryne L. Shaffer, Deborah B. Hobson, Peggy S. Kraus, Michael B. Streiff, Elliott R. Haut & Jonathan D’Cunha. (2018) Venous Thromboembolism in Patients Hospitalized for Lung Transplantation. The Annals of Thoracic Surgery 105:4, pages 1071-1076.
Crossref
Crossref
Matthew Mossanen, Ross E. Krasnow, Stuart R Lipsitz, Mark A. Preston, Adam S. Kibel, Albert Ha, John L. Gore, Angela B. Smith, Jeffrey J. Leow, Quoc-Dien Trinh & Steven L. Chang. (2018) Associations of specific postoperative complications with costs after radical cystectomy. BJU International 121:3, pages 428-436.
Crossref
Crossref
Junshik Hong, Ju Hyun Lee, Ho-Young Yhim, Won-Il Choi, Soo-Mee Bang, Heeyoung Lee & Doyeun Oh. (2018) Incidence of venous thromboembolism in Korea from 2009 to 2013. PLOS ONE 13:1, pages e0191897.
Crossref
Crossref
Megan K. Yee, Tarek Nafee, Yazan Daaboul, Serge Korjian, Fahad AlKhalfan, Mathieu Kerneis, Cara Wiest, Samuel Z. Goldhaber, Adrian F. Hernandez, Russell D. Hull, Alexander T. Cohen, Robert A. Harrington & C. Michael Gibson. (2017) Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial. Journal of Thrombosis and Thrombolysis 45:1, pages 1-8.
Crossref
Crossref
Jeffrey S. Berger, Roger Seheult, François Laliberté, Concetta Crivera, Dominique Lejeune, Yongling Xiao, Jeff Schein, Patrick Lefebvre & Scott Kaatz. (2018) Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism. Research and Practice in Thrombosis and Haemostasis 2:1, pages 58-68.
Crossref
Crossref
Brian K. YorkgitisOlubode A. Olufajo, David Metcalfe, Gally Reznor, Joaquim M. Havens, Zara Cooper & Ali Salim. (2017) Do Transferred Patients Increase the Risk of Venous Thromboembolism in Trauma Centers?. The American Surgeon 83:11, pages 1241-1245.
Crossref
Crossref
William V. Padula, Charles E. Phelps, Dane Moran & Christopher Earley. (2017) Allocating provider resources to diagnose and treat restless legs syndrome: a cost-utility analysis. Sleep Medicine 38, pages 44-49.
Crossref
Crossref
Sola Mansour, Ghazi Alotaibi, Cynthia Wu & Michael Sean McMurtry. (2017) Trends in admission rates and in-hospital stay for venous thromboembolism. Thrombosis Research 156, pages 149-154.
Crossref
Crossref
Nuria Rodríguez-Núñez, Alberto Ruano-Raviña, Romina Abelleira, Lucía Ferreiro, Adriana Lama, Francisco J. González-Barcala, Antonio Golpe, María E. Toubes, José M. Álvarez-Dobaño & Luis Valdés. (2017) Factores que influyen en la estancia hospitalaria por embolia pulmonar. Un estudio de cohortes. Archivos de Bronconeumología 53:8, pages 432-436.
Crossref
Crossref
Nuria Rodríguez-Núñez, Alberto Ruano-Raviña, Romina Abelleira, Lucía Ferreiro, Adriana Lama, Francisco J. González-Barcala, Antonio Golpe, María E. Toubes, José M. Álvarez-Dobaño & Luis Valdés. (2017) Factors Influencing Hospital Stay for Pulmonary Embolism. A Cohort Study. Archivos de Bronconeumología (English Edition) 53:8, pages 432-436.
Crossref
Crossref
Roy J. Weinberg, Tamuru Okada, Aaron Chen, Walter Kim, Changyi Chen & Peter H. Lin. (2017) Comparison of ASPIRE Mechanical Thrombectomy Versus AngioJet Thrombectomy System in a Porcine Iliac Vein Thrombosis Model. Annals of Vascular Surgery 42, pages 254-262.
Crossref
Crossref
George Dranitsaris, Lesley G Shane, Jean-Philippe Galanaud, Gunar Stemer, Philippe Debourdeau & Seth Woodruff. (2017) Dalteparin or vitamin K antagonists to prevent recurrent venous thromboembolism in cancer patients: a patient-level economic analysis for France and Austria. Supportive Care in Cancer 25:7, pages 2093-2102.
Crossref
Crossref
Christian Møller Dahl & Line Planck Kongstad. (2017) The costs of acute readmissions to a different hospital – Does the effect vary across provider types?. Social Science & Medicine 183, pages 116-125.
Crossref
Crossref
Wei Song, Hongbo Ci, Guanglei Tian, Yanjun Zhang & Xiaohu Ge. (2017) Edoxaban improves venous thrombosis via increasing hydrogen sulfide and homocysteine in rat model. Molecular Medicine Reports 16:5, pages 7706-7714.
Crossref
Crossref
J. Zhou, J. Kochan, O. Yin, V. Warren, C. Zamora, G. Atiee, J. Pav, Y. Orihashi, V. Vashi & V. Dishy. (2017) A first‐in‐human study of DS‐1040, an inhibitor of the activated form of thrombin‐activatable fibrinolysis inhibitor, in healthy subjects. Journal of Thrombosis and Haemostasis 15:5, pages 961-971.
Crossref
Crossref
Sarah Hudson Roberts & Sherry Motes Lawrence. (2017) CE. AJN, American Journal of Nursing 117:5, pages 38-47.
Crossref
Crossref
Emmeline Tran, Ashley Duckett, Sarah Fisher & Nicole Bohm. (2017) Appropriateness of direct oral anticoagulant dosing for venous thromboembolism treatment. Journal of Thrombosis and Thrombolysis 43:4, pages 505-513.
Crossref
Crossref
A. Carrillo Alcaraz, A. López Martínez & F.J. Sotos Solano. (2017) Diagnóstico de la embolia pulmonar. El punto de vista del médico clínico. Radiología 59:2, pages 166-176.
Crossref
Crossref
Keishi SUZUKI, Takeshi YAMAMOTO, Ikuyo TAKAGI, Erito FURUSE, Hideto SANGEN, Hiroshi HAYASHI, Hideki MIYACHI, Yusuke HOSOKAWA, Koichi AKUTSU & Wataru SHIMIZU. (2017) Impact of edoxaban approval for venous thromboembolism on length of hospitalization. Japanese Journal of Thrombosis and Hemostasis 28:1, pages 50-54.
Crossref
Crossref
Marloe Prince, Charles J. Glueck, Parth Shah, Ashwin Kumar, Michael Goldenberg, Matan Rothschild, Nasim Motayar, Vybhav Jetty, Kevin Lee & Ping Wang. (2016) Hospitalization for pulmonary embolism associated with antecedent testosterone or estrogen therapy in patients found to have familial and acquired thrombophilia. BMC Hematology 16:1.
Crossref
Crossref
Allison E. Berndtson, Todd W. Costantini, James Lane, Kevin Box & Raul Coimbra. (2016) If some is good, more is better. Journal of Trauma and Acute Care Surgery 81:6, pages 1095-1100.
Crossref
Crossref
George Dranitsaris, Lesley Shane, Laura Burgers & Seth Woodruff. (2016) Economic Analysis Comparing Dalteparin to Vitamin K Antagonists to Prevent Recurrent Venous Thromboembolism in Patients With Cancer Having Renal Impairment. Clinical and Applied Thrombosis/Hemostasis 22:7, pages 617-626.
Crossref
Crossref
Christopher C.Y. Wong, Austin C.C. Ng, Jerrett K. Lau, Vincent Chow, Andrew P. Sindone & Leonard Kritharides. (2016) The prognostic impact of chest pain in 1306 patients presenting with confirmed acute pulmonary embolism. International Journal of Cardiology 221, pages 794-799.
Crossref
Crossref
Charles J. Glueck, Kevin Lee, Marloe Prince, Vybhav Jetty, Parth Shah & Ping Wang. (2016) Four Thrombotic Events Over 5 Years, Two Pulmonary Emboli and Two Deep Venous Thrombosis, When Testosterone-HCG Therapy Was Continued Despite Concurrent Anticoagulation in a 55-Year-Old Man With Lupus Anticoagulant. Journal of Investigative Medicine High Impact Case Reports 4:3, pages 232470961666183.
Crossref
Crossref
Walter Ageno & Alexander Turpie. (2017) Spotlight on real-world evidence for the treatment of DVT: XALIA. Thrombosis and Haemostasis 116:S 02, pages S41-S49.
Crossref
Crossref
Torben Bjerregaard Larsen, Flemming Skjøth, Erik Lerkevang Grove, Peter Brønnum Nielsen & Thomas Decker Christensen. (2017) Effectiveness of self-managed oral anticoagulant therapy in patients with recurrent venous thromboembolism. Thrombosis and Haemostasis 116:09, pages 524-529.
Crossref
Crossref
. (2015) Costs for VTE treatment increasing. PharmacoEconomics & Outcomes News 736:1, pages 11-11.
Crossref
Crossref
Amit Bahl, Kim Alsbrooks, Smeet Gala & Klaus Hoerauf. (2022) Symptomatic Deep Vein Thrombosis Associated with Peripherally Inserted Central Catheter of Different Diameters: A Systematic Review and Meta-Analysis. SSRN Electronic Journal.
Crossref
Crossref